EPIX is currently conducting clinical trials for Alzheimer's disease. For more information, please visit http://www.trialforad.com.

For information about the PRX-03140 Phase 2a data, please call 866-514-2901.

October 6, 2008
EPIX Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference

September 30, 2008
EPIX Pharmaceuticals to Present at the 2008 Maxim Group Growth Conference

September 16, 2008
EPIX Pharmaceuticals Achieves Milestone from Collaboration with Cystic Fibrosis Foundation Therapeutics